The Dale and Betty Bumpers Vaccine Research Center (VRC) at the National Institutes of Health (NIH) was established to facilitate research in vaccine development. The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases. Established by former President Bill Clinton as part of and initiative to develop an AIDS vaccine, the VRC is a unique venture within the NIH intramural research program. Initially spearheaded by NIAID, the National Cancer Institute, and the NIH Office of AIDS Research, the VRC is now part of the NIAID organization.
John R. Mascola, M.D.
What's New:
-
Experimental Zika Virus DNA Vaccines Protective in Monkeys, September 22, 2016
-
NIH Begins Testing Investigational Zika Vaccine in Humans, August 3, 2016
The mission of the Vaccine Research Center (VRC) is to conduct research that facilitates the development of effective vaccines for human disease. The primary focus of research include:
For Researchers
- Viral Pathogenesis Laboratory
- Translational Research Program
- Vaccine Production Program
- Clinical Trials Program
- Virology Laboratory
- Humoral Immunology Section
- Structural Biology Section
- Immunology Laboratory
- Human Immunology Section
- ImmunoTechnology Section
- Cellular Immunology Section
- Biodefense Research Section